{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:22:42Z","timestamp":1771615362046,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psych Quart"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1007\/bf02238717","type":"journal-article","created":{"date-parts":[[2005,11,14]],"date-time":"2005-11-14T16:56:26Z","timestamp":1131987386000},"page":"87-95","source":"Crossref","is-referenced-by-count":38,"title":["Bromocriptine and psychosis: A literature review"],"prefix":"10.1007","volume":"66","author":[{"given":"Alan","family":"Boyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Feb","key":"BF02238717_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-6147(92)90025-2","volume":"13","author":"DR Sibley","year":"1992","unstructured":"Sibley DR, Monsma FJ, Jr: Molecular biology of dopamine receptors. Trends in Pharmacological Sciences 13(Feb):61\u201369, 1992.","journal-title":"Trends in Pharmacological Sciences"},{"key":"BF02238717_CR2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2265.1991.tb00928.x","volume":"35","author":"DF Wood","year":"1991","unstructured":"Wood DF, Johnston JM, Johnston DG: Dopamine, the dopamine receptor and putuitary tumors. Clinical Endocrinology 35:455\u2013466, 1991.","journal-title":"Clinical Endocrinology"},{"issue":"11","key":"BF02238717_CR3","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","volume":"148","author":"KL Davis","year":"1991","unstructured":"Davis KL, Kahn RS, Ko, G, et al: Dopamine in schizophrenia: a review and reconceptualization. American Journal of Psychiatry 148(11):1474\u20131486, 1991.","journal-title":"American Journal of Psychiatry"},{"key":"BF02238717_CR4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM197910183011606","volume":"301","author":"D Parkes","year":"1979","unstructured":"Parkes D: Bromocriptine. New England Journal of Medicine 301:873\u2013878, 1979.","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"BF02238717_CR5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(16)47111-6","volume":"39","author":"RE Blackwell","year":"1983","unstructured":"Blackwell RE, Bradley EL, Kline LB, et al: Comparison of dopamine agonists in the treatment of hyperprolactinemic syndromes: a multicenter study. Fertility and Sterility 39(6):744\u2013748, 1983.","journal-title":"Fertility and Sterility"},{"issue":"5","key":"BF02238717_CR6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0002-9343(84)91010-6","volume":"76","author":"RJ Robbins","year":"1984","unstructured":"Robbins RJ, Kern PA, Thompson TL: Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma. American Journal of Medicine 76(5):921\u2013923, 1984.","journal-title":"American Journal of Medicine"},{"key":"BF02238717_CR7","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/bmj.1.6115.790-a","volume":"1","author":"NM Brook","year":"1978","unstructured":"Brook NM, Cookson IB: Bromocriptine-induced mania? (Letter) British Medical Journal 1:790, 1978.","journal-title":"British Medical Journal"},{"key":"BF02238717_CR8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/bmj.1.6111.510-a","volume":"1","author":"DN Vlissides","year":"1978","unstructured":"Vlissides DN, Gill D, Castelow J: Bromocriptine-induced mania? (Letter) British Medical Journal 1:510, 1978.","journal-title":"British Medical Journal"},{"issue":"7985","key":"BF02238717_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(76)91816-X","volume":"2","author":"S Lipper","year":"1976","unstructured":"Lipper S: Psychosis in patient on bromocriptine and levodopa with carbidopa. Lancet 2(7985):571\u2013572, 1976.","journal-title":"Lancet"},{"key":"BF02238717_CR10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-2007-1017459","volume":"16","author":"HP Vogel","year":"1983","unstructured":"Vogel HP, Schiffter R: Hypersexuality \u2014 a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatry 16:107\u2013110, 1983.","journal-title":"Pharmacopsychiatry"},{"key":"BF02238717_CR11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/jnnp.52.6.773","volume":"52","author":"JL Montastruc","year":"1989","unstructured":"Montastruc JL, Rascol O, Rascol A: A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry 52:773\u2013775, 1989.","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"BF02238717_CR12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.1988.tb03668.x","volume":"78","author":"K Ostergaard","year":"1988","unstructured":"Ostergaard K, Dupont, E: Clozapine treatment of drug-induced psychotic symptoms of late stages of Parkinson's disease. Acta Neurologica Scandinavica 78:349\u2013350, 1988.","journal-title":"Acta Neurologica Scandinavica"},{"key":"BF02238717_CR13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00380972","volume":"235","author":"E Scholz","year":"1985","unstructured":"Scholz E, Dichgans J: Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapine. European Archives of Psychiatry and Neurological Sciences 235:60\u201364, 1985.","journal-title":"European Archives of Psychiatry and Neurological Sciences"},{"key":"BF02238717_CR14","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.135.10.1227","volume":"135","author":"M Serby","year":"1978","unstructured":"Serby M, Angrist B, Lieberman A: Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. American Journal of Psychiatry 135:1227\u20131229, 1978.","journal-title":"American Journal of Psychiatry"},{"key":"BF02238717_CR15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.1991.tb03627.x","volume":"39","author":"JL Cummings","year":"1991","unstructured":"Cummings, JL: Behavioral complications of drug treatment of Parkinson's disease. Journal of the American Geriatrics Society 39:708\u2013716, 1991.","journal-title":"Journal of the American Geriatrics Society"},{"issue":"8067","key":"BF02238717_CR16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(78)90856-5","volume":"1","author":"DB Calne","year":"1978","unstructured":"Calne DB, Williams AC, Neophytides A, et al: Long-term treatment of Parkinsonism with bromocriptine. Lancet 1(8067):735\u2013738, 1978.","journal-title":"Lancet"},{"key":"BF02238717_CR17","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1212\/WNL.35.8.1205","volume":"35","author":"K Burton","year":"1985","unstructured":"Burton K, Larsen TA, Robinson RG, et al: Parkinson's disease: a comparison of mesulergine and bromocriptine. Neurology 35:1205\u20131208, 1985.","journal-title":"Neurology"},{"issue":"5","key":"BF02238717_CR18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00002826-198710000-00011","volume":"10","author":"JH Friedman","year":"1987","unstructured":"Friedman JH, Max J, Swift, R: Idiopathic Parkinson's disease in a chronic schizophrenic patient: long-term treatment with clozapine and l-dopa. Clinical Neuropharmacology 10(5):470\u2013475, 1987.","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"BF02238717_CR19","first-page":"171","volume":"8","author":"L Iffy","year":"1989","unstructured":"Iffy L, Lindenthal J, Szodi Z, et al: Puerperal psychosis following ablaction with bromocriptine. Medicine and Law 8(2):171\u2013174, 1989.","journal-title":"Medicine and Law"},{"issue":"11","key":"BF02238717_CR20","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/00007611-198711000-00034","volume":"80","author":"RJ Canterbury","year":"1987","unstructured":"Canterbury RJ, Haskins B, Kahn N, et al: Postpartum psychosis induced by bromocriptine. Southern Medical Journal 80(11):1463\u20131464, 1987.","journal-title":"Southern Medical Journal"},{"key":"BF02238717_CR21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/014107688708000620","volume":"80","author":"CJF Kemperman","year":"1987","unstructured":"Kemperman CJF, Zwanniken GJ: Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea. Journal of the Royal Society of Medicine 80:387\u2013388, 1987.","journal-title":"Journal of the Royal Society of Medicine"},{"key":"BF02238717_CR22","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1177\/070674378703200810","volume":"32","author":"CR Lake","year":"1987","unstructured":"Lake CR, Reid A, Martin C, et al: Cyclothymic disorder and bromocriptine: predisposing factors for postpartum mania? Canadian Journal of Psychiatry 32:693\u2013694, 1987.","journal-title":"Canadian Journal of Psychiatry"},{"key":"BF02238717_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1445-5994.1979.tb04127.x","volume":"9","author":"K Steinbeck","year":"1979","unstructured":"Steinbeck K, Turtle JR: Treatment of acromegaly with bromocriptine. Australian and New Zealand Journal of Medicine 9:217\u2013224, 1979.","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"BF02238717_CR24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.285.6351.1315","volume":"285","author":"CM LeFeuvre","year":"1982","unstructured":"LeFeuvre CM, Isaacs AJ, Frank OS: Bromocriptine-induced psychosis in acromegaly. British Medical Journal 285:1315, 1982.","journal-title":"British Medical Journal"},{"key":"BF02238717_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-100-1-78","volume":"100","author":"ML Vance","year":"1984","unstructured":"Vance ML, Evans WS, Thorner MO: Bromocriptine. Annals of Internal Medicine 100:78\u201391, 1984.","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"BF02238717_CR26","first-page":"147","volume":"36","author":"GA Cabeza","year":"1984","unstructured":"Cabeza GA, Flores LF, Inigues IE, et al: Acute psychosis secondary to bromocriptine treatment in a patient with a prolactinoma. Revista de Investigacion Clinica 36(2):147\u2013149, 1984.","journal-title":"Revista de Investigacion Clinica"},{"issue":"May\u2013June","key":"BF02238717_CR27","first-page":"273","volume":"2","author":"TR Einarson","year":"1983","unstructured":"Einarson TR, Turchet, EN: Psychotic reaction to low-dose bromocriptine. Clinical Pharmacy 2(May\u2013June):273\u2013274, 1983.","journal-title":"Clinical Pharmacy"},{"key":"BF02238717_CR28","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1136\/bmj.289.6452.1101","volume":"289","author":"TH Turner","year":"1984","unstructured":"Turner TH, Cookson JC, Wass JAH, et al: Psychotic reactions during treatment of pituitary tumors with dopamine agonists. British Medical Journal 289:1101\u20131103, 1984.","journal-title":"British Medical Journal"},{"key":"BF02238717_CR29","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0006-3223(85)90062-9","volume":"20","author":"S Shukla","year":"1985","unstructured":"Shukla S, Turner WJ, Newman G: Bromocriptine-related psychosis and treatment. Biological Psychiatry 20:326\u2013328, 1985.","journal-title":"Biological Psychiatry"},{"issue":"7","key":"BF02238717_CR30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1176\/ajp.143.7.935b","volume":"143","author":"B Taneli","year":"1986","unstructured":"Taneli B, Ozaskinli S, Kirli S, et al: Bromocriptine-induced schizophrenic syndrome. American Journal of Psychiatry 143(7):935, 1986.","journal-title":"American Journal of Psychiatry"},{"key":"BF02238717_CR31","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/ajp.138.1.121-a","volume":"138","author":"JM Johnson","year":"1981","unstructured":"Johnson JM: Treated mania exacerbated by bromocriptine. American Journal of Psychiatry 138:980\u2013982, 1981.","journal-title":"American Journal of Psychiatry"},{"key":"BF02238717_CR32","first-page":"173","volume":"305","author":"KC Pearson","year":"1978","unstructured":"Pearson KC: Mental disorders from low dose bromocriptine (Letter). New England Journal of Medicine 305:173, 1978.","journal-title":"New England Journal of Medicine"},{"key":"BF02238717_CR33","first-page":"50","volume":"286","author":"AW Procter","year":"1983","unstructured":"Procter AW, Littlewood R, Fry AH: Bromocriptine-induced psychosis in acromegaly. British Medical Journal 286:50, 1983.","journal-title":"British Medical Journal"},{"issue":"6","key":"BF02238717_CR34","first-page":"252","volume":"43","author":"PE Frye","year":"1982","unstructured":"Frye PE, Pariser SF, Kim MH, et al: Bromocriptine associated with symptom exacerbation during neuroleptic treatment of schizoaffective schizophrenia. Journal of Clinical Psychiatry 43(6):252\u2013253, 1982.","journal-title":"Journal of Clinical Psychiatry"},{"key":"BF02238717_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00016349109007893","volume":"70","author":"A Dorevitch","year":"1991","unstructured":"Dorevitch A, Aronzon R, Stark M: Psychotic exacerbation attributed to low-dose bromocriptine treatment of galactorrhea and hyperprolactinemia. Acta Obstetricia et Gynecologica Scandinavica 70:375\u2013376, 1991.","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"BF02238717_CR36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0006-3223(90)90497-P","volume":"28","author":"WJ Turner","year":"1990","unstructured":"Turner WJ: Importance of treatment follow-up. Biological Psychiatry 28:551\u2013554, 1990.","journal-title":"Biological Psychiatry"},{"issue":"Nov\u2013Dec","key":"BF02238717_CR37","first-page":"512","volume":"2","author":"TR Einarson","year":"1983","unstructured":"Einarson TR, Turchet EN: Follow-up on bromocriptine-induced psychosis. Clinical Pharmacy 2(Nov\u2013Dec):512, 1983.","journal-title":"Clinical Pharmacy"},{"key":"BF02238717_CR38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1192\/bjp.124.5.413","volume":"124","author":"PJV Beaumont","year":"1974","unstructured":"Beaumont PJV, Gelder MG, Friesen HG, et al: The effects of phenothiazines on endocrine function: I Patients with inappropriate lactation and amenorrhea. British Journal of Psychiatry 124:413\u2013419, 1974.","journal-title":"British Journal of Psychiatry"},{"key":"BF02238717_CR39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.126.3.285","volume":"126","author":"P Beaumont","year":"1975","unstructured":"Beaumont P, Bruwer J, Pimstone B, et al: Brom-ergocryptine in the treatment of phenothiazine-induced galactorrhea. British Journal of Psychiatry 126:285\u2013288, 1975.","journal-title":"British Journal of Psychiatry"},{"issue":"6","key":"BF02238717_CR40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004714-198912000-00006","volume":"9","author":"RM Perovich","year":"1989","unstructured":"Perovich RM, Lieberman JA, Fleischhacker WW, et al: The behavioral toxicity of bromocriptine in patients with psychiatric illness. Journal of Clinical Psychopharmacology 9(6):417\u2013422, 1989.","journal-title":"Journal of Clinical Psychopharmacology"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02238717.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02238717\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02238717","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:12:59Z","timestamp":1557940379000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02238717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["BF02238717"],"URL":"https:\/\/doi.org\/10.1007\/bf02238717","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}